Abteilung Hämatologie / Transfusionsmedizin
Byskov K, Etscheid M, Kanse SM (2020): Cellular Effects of Factor VII Activating Protease (FSAP).
Thromb Res 188: 74-78.
Online-Abstract
Domanovic D, Gossner CM, Lieshout-Krikke R, Mayr W, Baroti-Toth K, Dobrota AM, Escoval MA, Henseler O, Jungbauer C, Liumbruno G, Oyonarte S, Politis C, Sandid I, Stojic Vidovic M, Young JJ, Ushiro-Lumb I, Nowotny N (2019): West Nile and Usutu Virus Infections and Challenges to Blood Safety in the European Union.
Emerg Infect Dis 25: 1050-1057.
Text
Duda H, Hesse J, Haschberger B, Hilger A, Keipert C (2020): The German Hemophilia Registry: Growing with Its Tasks.
J Clin Med 9: E3408.
Online-Abstract
Fiedler SA, Boller K, Junker AC, Kamp C, Hilger A, Schwarz W, Seitz R, Salge-Bartels U (2020): Evaluation of the in vitro function of platelet concentrates from pooled buffy coats or apheresis.
Transfus Med Hemother 47: 314-324.
Text
Fiedler SA, Oberle D, Chudy M, Scheiblauer H, Henseler O, Halbauer J, Heiden M, Funk MB (2019): Effectiveness of blood donor screening by HIV, HCV, HBV‐NAT assays, as well as HBsAg and anti‐HBc immunoassays in Germany (2008–2015).
Vox Sang 114: 443-450.
Online-Abstract
Kafere C, Tayou Tagny C, Tapko JB, Mbunkah HA, Samukange WT, Mutoti K, Mudyiwenyama L, Sumaila A, Reinhardt J (2020): Congress Report: Implementation of Blood and Blood Product Regulation Training Workshop, South Africa.
Africa Sanguine 22: 5-9.
Text
Karamloo F, König R (2020): SARS-CoV-2 immunogenicity at the crossroads.
Allergy 75: 1822-1824.
Online-Abstract
Keipert C, Müller-Olling M, Gauly F, Arras-Reiter C, Hilger A (2020): Annual Bleeding Rates: Pitfalls of Clinical Trial Outcomes in Hemophilia Patients.
Clin Transl Sci 13: 1127-1136.
Text
Mbunkah HA, Reinhardt J, Kafere C, Scheiblauer H, Prat I, Nübling CM (2021): In vitro diagnostics for screening the blood supply: the new European regulation for IVD and the WHO IVD prequalification programme.
Vox Sang 116: 3-12.
Text
Nielsen NV, Roedel E, Manna D, Etscheid M, Morth JP, Kanse SM (2019): Characterization of the enzymatic activity of the serine protease domain of Factor VII activating protease (FSAP).
Sci Rep 9: 18990.
Text
Ovanesov MV, Williams SC, Nübling CM, Dodt J, Hilger A, Maryuningsih Y, Gray E (2020): Summary of the WHO hearing on the development of product-specific reference materials for coagulation factor VIII and factor IX products.
Biologicals 67: 88-93.
Online-Abstract
Peyvandi F, Berger K, Seitz R, Hilger A, Hecquet ML, Wierer M, Buchheit KH, O'Mahony B, Bok A, Makris M, Mansmann U, Schramm W, Mannucci PM (2020): Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies.
Haemotologica 105: 2038-2043.
Text
Pierce GF, Coffin D, Members of the WFH Gene Therapy Round Table Program Committee and Orgazining Committee, Lillicrap D, Ozelo M, Pasi J, Rotellini D, Marquez S, Sannié T, Srivastava A, den Berg M, Weill A, Almeida A, Baumann A, Brooker M, Durante L, Naccache M, Robinson F, Bagley L, Chapin J, Diop S, El Ekiaby M, Flume M, George L, Grehan J, Hawe M, High K, Hilger A, Jonsson B, Kim J, Kimmelman J, Kobelt G, Lee M, Lillicrap D, Linares A, Lozier J, Mahlangu J, Makris M, Marten K, Mathew P, Noone D, O'Hara J, Ozelo M, Ohmori T, Page D, Pasi J, Perry J, Pierce G, Hernandez P, Ragni M, Rakha M, Rayner B, Reiss U, Rollmann D, Rotellini D, Ruff P, Ruiz S, Marquez S, Sannié T, Sathyanarayanan R, Skinner M, Srivastava A, Tortella B, Tuddenham E, Valentino L, den Berg M, Vandendriessche T, Weill A, Yang R, Zelenkofske S (2019): The 1st WFH Gene Therapy Round Table: Understanding the landscape and challenges of gene therapy for haemophilia around the world.
Haemophilia 25: 189-194.
Text
Pinz A, Altrichter-Dünnes S, Ateba Ngoa U, Atemnkeng J, Heinrich K, Conrad C, Reinhardt J (2020): E-learning approach for capacity building in the area of regulatory systems strengthening in Africa.
Transfus Med Hemother 47: 13.
Online-Abstract
Samukange WT, Klümpers V, Kafere C, Schuler F, Tirane FJ, Kabaso B, Chama D, Ejeh EA, Reinhardt J (2020): Report from the GHPP-BloodTrain inspection workshop in Harare the 20th to the 24th of May 2019.
Biologicals 68: 125-128.
Online-Abstract
Schramm W, Seitz R, Gürtler L (2020): COVID-19-associated coagulopathy - Hypothesis: Are Children protected due to enhanced thrombin inhibition by higher α2 -Macroglobulin (α2-M)?.
J Thromb Haemost 18: 2416-2418.
Online-Abstract
Seenivasan R, Hermanns T, Blyszcz T, Lammers M, Praefcke GJK, Hofmann K (2019): Mechanism and chain specificity of RNF216/TRIAD3, the ubiquitin ligase mutated in Gordon Holmes syndrome.
Hum Mol Genet 28: 2862-2873.
Online-Abstract
Seitz R, Gürtler L, Schramm W (2021): Thromboinflammation in COVID-19: Can α2-Macroglobulin Help to Control the Fire?.
J Thromb Haemost 19: 351-354.
Online-Abstract
Seitz R, Schramm W (2020): DIC in COVID-19: Implications for Prognosis and Treatment?.
J Thromb Haemost 18: 1798-1799.
Online-Abstract
Singh S, Akhter MS, Dodt J, Sharma A, Kaniyappan S, Yadegari H, Ivaskevicius V, Oldenburg J, Biswas A (2019): Disruption of Structural Disulfides of Coagulation FXIII-B Subunit; Functional Implications for a Rare Bleeding Disorder.
Int J Mol Sci 20: 1956.
Text
Singh S, Akhter MS, Dodt J, Volkers P, Reuter A, Reinhart C, Krettler C, Oldenburg J, Biswas A (2019): Identification of Potential Novel Interacting Partners for Coagulation Factor XIII B (FXIII-B) Subunit, a Protein Associated with a Rare Bleeding Disorder.
Int J Mol Sci 20: 2682.
Online-Abstract
Singh S, Dodt J, Volkers P, Hethershaw E, Philippou H, Ivaskevicius V, Imhof D, Oldenburg J, Biswas A (2019): Structure functional insights into calcium binding during the activation of coagulation factor XIII A.
Sci Rep 9: 11324.
Online-Abstract
Sriramachandran AM, Meyer-Teschendorf K, Pabst S, Ulrich HD, Gehring NH, Hofmann K, Praefcke GJK, Dohmen RJ (2019): Arkadia/RNF111 is a SUMO-targeted ubiquitin ligase with preference for substrates marked with SUMO1-capped SUMO2/3 chain.
Nat Commun 10: 3678.
Online-Abstract